Interesting, the outcome of the meta study I read that was focused solely on CBC and insomnia indicated the following: ”The results of our systematic review suggest that CBD alone or with equal quantities of THC may be beneficial in alleviating the symptoms of insomnia. Nevertheless, future research assessing CBDs effectiveness in population of patients specifically with insomnia utilizing validated subjective and objective measures is necessary before definitive inferences can be made”. You can read the synopsis for yourself… but, from listening to the webinar on Tuesday, AVE are very clear on focusing on insomnia and selecting trial participants that will have the best chance of achieving significant improvements, we will just have to wait and see how the interim results due 2026 indicate. (https://pubmed.ncbi.nlm.nih.gov/36149724/)
AVE Price at posting:
0.6¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)